Given the regulatory relationship between miRNA and GLUT4, GULT4 may also be another novel target during PCOS therapy (Chakraborty et al., 2014; Gebremedhn et al., 2021). The gene discussed is SLC2A4; the disease is polycystic ovary syndrome.